Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study von Walter, T., Lepage, C., Coriat, R., Barbier, E., Cadiot, G., Caroli Bosc, F.X., Aparicio, T., Bouhier Leporrier, K., Hentic Dhome, O., Dupont-Gossart, A.-C., Duluc, M., Lepere, C., Lecomte, T., Smith, D., Petorin, C., Iwanicki Caron, I., Ducreux, M.P., Lombard Bohas, C., de Baere, T.

Volltext

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer von Conroy, Thierry, Hammel, Pascal, Hebbar, Mohamed, Ben Abdelghani, Meher, Wei, Alice C, Raoul, Jean-Luc, Choné, Laurence, Francois, Eric, Artru, Pascal, Biagi, James J, Lecomte, Thierry, Assenat, Eric, Faroux, Roger, Ychou, Marc, Volet, Julien, Sauvanet, Alain, Breysacher, Gilles, Di Fiore, Frédéric, Cripps, Christine, Kavan, Petr, Texereau, Patrick, Bouhier-Leporrier, Karine, Khemissa-Akouz, Faiza, Legoux, Jean-Louis, Juzyna, Béata, Gourgou, Sophie, O’Callaghan, Christopher J, Jouffroy-Zeller, Claire, Rat, Patrick, Malka, David, Castan, Florence, Bachet, Jean-Baptiste

Volltext

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial von Bennouna, Jaafar, MD, Sastre, Javier, MD, Arnold, Dirk, Prof, Österlund, Pia, MD, Greil, Richard, Prof, Van Cutsem, Eric, Prof, von Moos, Roger, MD, Viéitez, Jose Maria, MD, Bouché, Olivier, Prof, Borg, Christophe, MD, Steffens, Claus-Christoph, MD, Alonso-Orduña, Vicente, MD, Schlichting, Christoph, MD, Reyes-Rivera, Irmarie, MD, Bendahmane, Belguendouz, MD, André, Thierry, Prof, Kubicka, Stefan, Prof

Volltext

Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach von Boisdron-Celle, M, Capitain, O, Faroux, R, Borg, C, Metges, J.P, Galais, M.P, Kaassis, M, Bennouna, J, Bouhier-Leporrier, K, Francois, E, Baumgaertner, I, Guerin-Meyer, V, Cojocarasu, O, Roemer-Becuwe, C, Stampfli, C, Rosenfeld, L, Lecompte, T, Berger, V, Morel, A, Gamelin, E

Volltext

449TiP Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study von Tron, C., Lemaitre, F., Locher, C., Lecomte, T., Tournigand, C., Bouhier Leporrier, K., Le Sourd, S., Metges, J-P., Tougeron, D., Di Fiore, F., Hervé, C., Heran, M., Touchefeu, Y., Rousseau, B.J-C., Hulin, A., Lievre, A.

Volltext

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials von Barbier, Emilie, François, Eric, Michel, Pierre, Rougier, Philippe, Seitz, Jean-François, Aouakli, A., Bedjaoui, A., Botton, A., Cadier-Lagnes, A., Hollebecque, A., Lemaire, A., Marre, A., Villing, A.L., Denis, B., Becht, C., Bineau, C., Borel, C., Buffet, C., Cornila, C., Couffon, C., Locher, C., Rebischung, C., Sarda, C., Auby, D., Baudet-Klepping, D., Besson, D., Cleau, D., Festin, D., Genet, D., Peré-Vergé, D., Pillon, D., Smith, D., Dorval Danquechin, E., Maillard, E., Mitry, E., Suc, E., Zrihen, E., Pariente, E.A., Dewaele, F., Di Fiore, F., Husseini, F., Kikolski, F., Petit-Laurent, F., Zerouala-Boussaha, F., Caroli-Bosc, F.X., Boilleau-Jolimoy, G., Medinger, G., Graber, I., Charneau, J., Cretin, J., Deguiral, J., Lacourt, J., Meunier, J., Vincent, J., Volet, J., Barbare, J.C., Paitel, J.F., Raoul, J.L., Gornet, J.M., Aucouturier, J.P., Barbieux, J.P., Plachot, J.P., Ramain, J.P., Spano, J.P., Bouhier-Leporrier, K., Cany, L., Rob, L., Baconnier, M., Benchalal, M., Combe, M., Duluc, M., Giovannini, M., Mabro, M., Ramdani, M., Tissot, M., Clavero-Fabri, M.C., Gouttebel, M.C., Kaminsky, M.C., Stremsdoerfer, N., Burtin, P., Cassan, P., Claudé, P., Couzigou, P., Geoffroy, P., Godeau, P., Hammel, P., Novello, P., Prost, P., Ruszniewski, P., Texereau, P., Coriat, R., Nasca, S., Fratte, S.P., Mansourbakht, T., Walter, T., Derias, V., Jestin Le Tallec, V., Sebbagh, V., Adhoute, X., Becouarn, Y.

Volltext

Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff von Benoist, Hubert, Busson, Amandine, Faveyrial, Audrey, Bouhier-Leporrier, Karine, Divanon, Fabienne, Breuil, Cécile, Roger-Leenaert, Sophie, Palix, Agnès, Odou, Pascal, Simon, Nicolas, Saint-Lorant, Guillaume

Volltext

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study... von Kubicka, S., André, T., von Moos, R., Österlund, P., Reyes-Rivera, I., Müller, T., Arnold, D., Balcke, P., Benedicic, B., Eisterer, W., Fridrik, M., Samonigg, H., Arts, J., De Man, M., Janssens, J., Benczikova, B., Prausova, J., Vitek, P., Jensen, B.B., Keldsen, N., Østerlind, K., Borg, C., Breysacher, G., Chone, L., Dourthe, L.-M., Faroux, R., Illory, J.F., Lecomte, T., Legoux, J.-L., Levache, B., Lotz, J.-P., Mabro, M., Manfredi, S., Matysiak Budnik, T., Miglianico, L., Pezet, D., Porneuf, M., Tournigand, C., Viret, F., Ychou, M., Bangerter, M., Bertram, M.E., Bohnsteen, B., Cordes, H.-J., Eggert, J., Engel, E., Florschütz, A., Freier, W., Freund, M., Göhler, T., Hagen, V., Hebart, H.F., Heike, M., Höffkes, H.-G., Kettner, E., Kneba, M., Kojouharoff, G., Kretzschmar, A., Kröning, H., Lammert, F., Papke, J., Rädle, J., Ridwelski, K., Rudi, J., Schmalenberger, A., Schwarzer, A., Schwerdtfeger, M., Selbach, J., Staib, P., Stauch, M., Steffens, C.-C., Stübs, P., Tischendorf, J., Tummes, D., Von Wichert, G.P.L., Zomorodbaksch, B., Bloemendal, H.J., Guren, T., Soerbye, H., Fragoso, R., Mellidez, J.C., Darwish, T., Aparicio, J., Aranda, E., Camara, J.C., Donnay, O., Escudero, P., Gallego Plazas, J., Gonzalez Flores, E., Gravalos, C., Guardeno, R., Juárez, A., Massuti Sureda, B., Tobena, M., Toral, J.C., Valenti, V., Berglund, A., Fernebro, E., Hess-Umbricht, V., Popescu, R.

Volltext

1312PDEverolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study von Walter, T, Lepage, C, Coriat, R, Barbier, E, Cadiot, G, Caroli Bosc, F X, Aparicio, T, Bouhier Leporrier, K, Hentic Dhome, O, Dupont-Gossart, A-C, Duluc, M, Lepere, C, Lecomte, T, Smith, D, Petorin, C, Iwanicki Caron, I, Ducreux, M P, Lombard Bohas, C, de Baere, T

Volltext

6124 Cetuximab specific IgE antibodies can predict cetuximab-induced anaphylaxis von Dupont, B, Mariotte, D, Galais, M.P, Bouhier-Leporrier, K, Laroche, D, Reimund, J.M, Le Mauff, B, Gervais, R

Volltext

Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial von Edeline, J., Bonnetain, F., Phelip, J-M., Watelet, J., Hammel, P., Joly, J-P., Benabdelghani, M., Fartoux, L., Bouhier-Leporrier, K., Jouve, J-L., Faroux, R., Guerin-Meyer, V., Assenat, E., Seitz, J-F., Malka, D., Louvet, C., Bertaut, A., Juzyna, B., Stanbury, T., Boucher, E.

Volltext

Prospective analysis of CEA, CA19.9, circulating DNA (cDNA) and circulating tumor cells (CTC) in patients (pts) treated for a metastatic colorectal cancer (mCRC)_Results of COCA-CO... von Sefrioui, D., Vasseur, N., Toure, E., Blanchard, F., Delacour, J., Thill, C., Beaussire, L., Gillibert, A., Ziegler, F., Gangloff, A., Bouhier-Leporrier, K., Lefebvre, A.-C., Parzy, A., Gallais, M.-P., Clatot, F., Perdrix, A., Sabourin, J.-C., Frebourg, T., Michel, P., Di Fiore, F.

Volltext

Evaluation of current practice: management of chemotherapy-related toxicities von Lheureux, Stéphanie, Clarisse, Bénédicte, Launay-Vacher, Vincent, Gunzer, Katharina, Delcambre-Lair, Corinne, Bouhier-Leporrier, Karine, Kaluzinski, Laure, Maron, Dominique, Ngo, Minh-Dung, Grossi, Sara, Dubois, Brice, Zalcman, Gérard, Joly, Florence

Volltext

FOLFIRI followed by radiochemotherapy and surgery in locally advanced gastric cancer: FFCD 0308 phase II trial von Michel, P., Breysacher, G., Desseigne, F., Dahan, L., Petorin, C., Moussata, D., Grenier, J., Nguyen, S., Viret, F., Carrere, N., Mariette, C., Garnier Tixidre, C., Bouhier Leporrier, K., Galais, M., Fein, F., Iwanicki- Caron, I., Maillard, E., Dousset, B., Mornex, F., Bedenne, L.

Volltext

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort von Walter, T, Tougeron, D, Baudin, E, Le Malicot, K, Lecomte, T, Malka, D, Hentic, O, Manfredi, S, Bonnet, I, Guimbaud, R, Coriat, R, Lepère, C, Desauw, C, Thirot-Bidault, A, Dahan, L, Roquin, G, Aparicio, T, Legoux, J.-L, Lombard-Bohas, C, Scoazec, J.-Y, Lepage, C, Cadiot, G

Volltext